Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

The BHBS is a valid tool to study cultural norms and breast cancer risk in Black women.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Various techniques and tools for hair restoration were presented in 1998, including a mathematical model for donor area, use of lasers in surgery, methods for controlling grafted hair direction, and ways to increase graft yield. Satisfaction rates were around 39%, and studies showed trauma and dehydration can damage hair follicles.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.